Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Follistatin-344 Before and After: Protocol Comparison

Follistatin-344 outcomes depend on dosing frequency, training structure, and baseline phenotype. The table below summarizes three common research protocols and their observed results in controlled settings. Low-Dose Maintenance 100mcg every 72 hours Moderate r

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Follistatin-344 outcomes depend on dosing frequency, training structure, and baseline phenotype. The table below summarizes three common research protocols and their observed results in controlled settings.
  • Low-Dose Maintenance
  • 100mcg every 72 hours
  • Moderate resistance training 3x/week
  • 3.2–5.1% lean mass increase
  • 40–55% reduction from baseline
  • Suitable for maintenance phase or older populations. Minimal side effect profile but slower accrual
  • Standard Protocol
  • 200mcg every 48 hours
  • High-volume resistance training 4–5x/week
  • 6.8–9.2% lean mass increase
  • 75–85% reduction from baseline
  • Most common research dosing. Balances efficacy with tolerability, requires structured training
  • High-Dose Investigational
  • 300mcg daily
  • Periodized strength training 5–6x/week
  • 8.1–11.4% lean mass increase
  • 85–95% reduction from baseline
  • Approaching receptor saturation ceiling. Marginal gains over 200mcg protocol, higher cost and injection burden